Company / Return on Equity (ROE)
Repligen Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
2.3%
FY2025
5-year range
-1.3% / 9.7%
FY2021-FY2025
Trend
+279.8%
vs FY2024
Sector context
#48 of 190
Health Care
What the data says
Return on Equity (ROE) changed +280% YoY in FY2025, a notable deviation from the 9-year average annual change of +16%.
Based on SEC 10-K filings.
2.3% in FY2025 with a 5-year CAGR of -1.6%. Top quartile in the Health Care sector.
Improved from 1.8% to 2.3% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -7.4pp
- 5-Year Change
- -1.6pp
- 10-Year Change
- -
Sector benchmark
Top 25% in Health CareTop 25% of 190This company 2.3% Sector average -50.4%
▼
+104.6% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 279.8% year-over-year.
- Currently 52.7pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2022.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.3% | +279.8% |
| FY2024 | -1.3% | -171.3% |
| FY2023 | 1.8% | -81.4% |
| FY2022 | 9.7% | +32.7% |
| FY2021 | 7.3% | +87.0% |
| FY2020 | 3.9% | +94.1% |
| FY2019 | 2.0% | -25.2% |
| FY2018 | 2.7% | -43.6% |
| FY2017 | 4.8% | -30.8% |
| FY2016 | 6.9% | -55.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026